Next Article in Journal
Conflict of Interest in Health Technology Assessment Decisions: Case Law in France and Impact on Reimbursement Decisions
Previous Article in Journal
A Review of Accessibility of Administrative Healthcare Databases in the Asia-Pacific Region
 
 
Journal of Market Access & Health Policy (JMAHP) is published by MDPI from Volume 12 Issue 1 (2024). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Taylor & Francis.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Comparison of HAS & NICE Guidelines for the Economic Evaluation of Health Technologies in the Context of Their Respective National Health Care Systems and Cultural Environments

by
Marc Massetti
1,*,
Samuel Aballéa
1,
Yann Videau
2,
Cécile Rémuzat
1,
Julie Roïz
3 and
Mondher Toumi
4
1
Creativ-Ceutical, Paris, France
2
ERUDITE - TEPP (Travail, Emploi et Politique Publique) FR CNRS 3126, Université Paris-Est Créteil Val-de-Marne, Paris, France
3
Creativ-Ceutical, London, UK
4
Public Health: Quality of Life and Chronic Diseases EA3279, Université de la Méditerranée, Marseille, France
*
Author to whom correspondence should be addressed.
J. Mark. Access Health Policy 2015, 3(1), 24966; https://doi.org/10.3402/jmahp.v3.24966
Submission received: 19 May 2014 / Revised: 1 November 2015 / Accepted: 1 November 2015 / Published: 12 March 2015

Abstract

Background: Health technology assessment (HTA) has been reinforced in France, notably with the introduction of economic evaluation in the pricing process for the most innovative and expensive treatments. Similarly to the National Institute for Clinical Excellence (NICE) in England, the National Authority for Health (HAS), which is responsible for economic evaluation of new health technologies in France, has published recommendations on the methods of economic evaluation. Since economic assessment represents a major element of HTA in England, exploring the differences between these methodological guidelines might help to comprehend both the shape and the role economic assessment is intended to have in the French health care system. Methods: Methodological guidelines for economic evaluation in France and England have been compared topic-by-topic in order to bring out key differences in the recommended methods for economic evaluation. Results: The analysis of both guidelines has revealed multiple similarities between France and England, although a number of differences were also noted regarding the elected methodology of analysis, the comparison of studies’ outcomes with cost-effectiveness thresholds, the study population to consider, the quality of life valuation methods, the perspective on costs, the types of resources considered and their valuation, the discount rates to apply in order to reflect the present value of interventions, etc. To account for these differences, modifications will be required in order to adapt economic models from one country to the other. Conclusion: Changes in HTA assessment methods occur in response to different challenges determined by the different philosophical and cultural considerations surrounding health and welfare as well as the political considerations regarding the role of public policies and the importance of their evaluation.
Keywords: health technology assessment; guidelines; France; UK; economic evaluation health technology assessment; guidelines; France; UK; economic evaluation

Share and Cite

MDPI and ACS Style

Massetti, M.; Aballéa, S.; Videau, Y.; Rémuzat, C.; Roïz, J.; Toumi, M. A Comparison of HAS & NICE Guidelines for the Economic Evaluation of Health Technologies in the Context of Their Respective National Health Care Systems and Cultural Environments. J. Mark. Access Health Policy 2015, 3, 24966. https://doi.org/10.3402/jmahp.v3.24966

AMA Style

Massetti M, Aballéa S, Videau Y, Rémuzat C, Roïz J, Toumi M. A Comparison of HAS & NICE Guidelines for the Economic Evaluation of Health Technologies in the Context of Their Respective National Health Care Systems and Cultural Environments. Journal of Market Access & Health Policy. 2015; 3(1):24966. https://doi.org/10.3402/jmahp.v3.24966

Chicago/Turabian Style

Massetti, Marc, Samuel Aballéa, Yann Videau, Cécile Rémuzat, Julie Roïz, and Mondher Toumi. 2015. "A Comparison of HAS & NICE Guidelines for the Economic Evaluation of Health Technologies in the Context of Their Respective National Health Care Systems and Cultural Environments" Journal of Market Access & Health Policy 3, no. 1: 24966. https://doi.org/10.3402/jmahp.v3.24966

APA Style

Massetti, M., Aballéa, S., Videau, Y., Rémuzat, C., Roïz, J., & Toumi, M. (2015). A Comparison of HAS & NICE Guidelines for the Economic Evaluation of Health Technologies in the Context of Their Respective National Health Care Systems and Cultural Environments. Journal of Market Access & Health Policy, 3(1), 24966. https://doi.org/10.3402/jmahp.v3.24966

Article Metrics

Back to TopTop